Author:
Tan Eunice Xiang-Xuan,Lee Jonathan Wei-Jie,Jumat Nur Halisah,Chan Wah-Kheong,Treeprasertsuk Sombat,Goh George Boon-Bee,Fan Jian-Gao,Song Myeong Jun,Charatcharoenwitthaya Phunchai,Duseja Ajay,Imajo Kento,Nakajima Atsushi,Seki Yosuke,Kasama Kazunori,Kakizaki Satoru,Lesmana Laurentius A.,Zheng Kenneth I.,Zheng Ming-Hua,Koh Calvin J.,Ho Khek-Yu,Goh Khean-Lee,Wong Vincent Wai-Sun,Dan Yock-Young
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference46 articles.
1. Non-alcoholic fatty liver disease;Powell;Lancet,2021
2. Modelling NAFLD disease burden in four Asian regions—2019-2030;Estes;Aliment Pharmacol Ther,2020
3. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis;Li;Lancet Gastroenterol Hepatol,2019
4. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis;Ye;Lancet Gastroenterol Hepatol,2020
5. 379 characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease;Cruz;Gastroenterology,2014